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Discovery of novel CTL epitopes by peptide library screening of CTL lines 
from Theileria parva immune animals 
ABSTRACT
The parasite Theileria parva claims the life of
approximately 1 million cattle every year. Immune animals to the
parasite develop a lifelong immunity based on a cytotoxic T
lymphocyte (CTL) response with a strong immunodominance
restricted by the bovine leukocyte antigen (BoLA) class I
molecules. In our goal of developing a next-generation vaccine
against T. parva, we have undertaken to identify new CTL
inducing antigens that can be included in a recombinant vaccine.
A peptide library of 18-mer peptides overlapping by 12 amino
acids and covering 500 genes of the whole parasite genome was
synthesized; giving approximately 40,000 peptides aliquoted in
pools of 50 peptides. Genes were selected based on the presence
of a signal peptide, abundance, and divergence to the related
parasite T. annulata, as well as by a selection using
immunoinformatic tools predicting, by artificial neural network,
peptides binding with strong affinity to the BoLA class I molecules
present in cattle of Africa. A bank of ten CTL lines from cattle
immunized with the live parasite expressing different BoLA class I
specificities were screened by IFN- ELISpot assay. Among these
cells, four secreted IFN- in the presence of a different peptide
library pool. Peptides from these pools were synthesized and
positive individual 18-mer peptides were identified. Dissection of
the minimal epitope is underway using IFN- ELISpot, cytotoxicity
as well as peptide-BoLA class I flow cytometry assays. These
newly identified antigens will hopefully allow us to develop a
vaccine towards T. parva giving wide coverage in cattle
population with diverse BoLA class I molecules.
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INFECTION & TREATMENT METHOD (ITM) 
OF VACCINATION
Positive peptides (TpMuguga_04g00772):
TLTLQGHRMKVTNLKWNPG (D5.31)
HRMKVTNLKWNPTVDYALG   (lD5.32)
Positive peptides (TpMuguga_01g01091 [Tp12]):
DTLDSNREQLLNQFYQLFG     (E4.34)
REQLLNQFYQLFNTPVDQG    (E4.35)
Cell line MHC Haplotype Epitope Screening
F100 (B) A10/KN104 N.A. Positive
BX64 (B) A10/KN104 N.A. Positive
BF091 A18/A11/A19 Tp1214-224 Negative
BB007 A18/? Tp1214-224 Negative
BF092 A18/A12 Tp1214-224 Positive
BK173 A14 Not reacting to Tp9 Negative
BA219 A18 Tp1214-224 Negative
BH055 A11/A15v Tp5214-224 Negative
BG042 A10/A12 Not reacting to Tp2 Negative
BW012(B) T7/? Tp7206-214 Positive 
PARTNERS FUNDING
SUMMARY & PERSPECTIVE
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Haplotype Frequency in Cattle 
N=127
4
4 chromosomes
≈ 4,000 genes
Theileria
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- Abundance
- Signal peptide
- Divergence to T. annulata
- Promiscuity to 
BoLA class I molecules (NetMHCpan)
Selection of 500 genes  40,000 peptides
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B in d e r  1
B in d e r  2
N o n -b in d e r  1
N o n -b in d e r  2
F100.1 TLTLQGHRMKVT
F100.2 LTLQGHRMKVTN
F100.3 TLQGHRMKVTNL
F100.4 LQGHRMKVTNLK
F100.5 QGHRMKVTNLKW
F100.6 GHRMKVTNLKWN
F100.7 HRMKVTNLKWNP
F100.8 RMKVTNLKWNPT
F100.9 MKVTNLKWNPTV
F100.10 KVTNLKWNPTVD
F100.11 VTNLKWNPTVDY
F100.12 TNLKWNPTVDYA
F100.13 NLKWNPTVDYAL
MHC CLASS I HAPLOTYPE FREQUENCIES 
IN CATTLE
SELECTION OF PEPTIDES
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NEW ANTIGEN IDENTIFIED WITH F100 CTL
6
POSITIVE PEPTIDES IDENTIFIED WITH BF092 CTL
IFN ELISpot Assay
IFN ELISpot Assay
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IFN ELISpot Assay
- 4 new epitopes under identification;
- Restricting BoLA class I molecule need to be 
identified;
- Minimal epitope sequence will be confirmed 
by ELISpot, cytotoxicity assay as well as by:
A) BoLA class I monomer binding assay
B) peptide-BoLA class I tetramer staining of positive cells
Tetramer+
C
D
8
+
The figure illustrates the different life cycle stages of the 
parasite as it cycles through the mammalian and tick host.
Induction of a strong 
CTL response
negative positive
Looking for the minimal epitope:
A20
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